Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
July 10, 2014
[A dyspnoeic male with abnormal QRS complexes]
Joeri A J Douma, Jeroen Schotten
Nederlands Tijdschrift Voor Geneeskunde
|
August 7, 2015
[Loperamide for acute infectious diarrhoea]
Joeri A J Douma, Yvo M Smulders
Nederlands Tijdschrift Voor Geneeskunde
|
December 5, 2013
[A woman with acute abdominal pain in the night]
Joeri A J Douma, Frans van Hoorn, Rob J L Klaassen
BMC Cancer
|
October 31, 2018
Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer
Joeri A J Douma, Henk M W Verheul, Laurien M Buffart
The American Journal of Tropical Medicine and Hygiene
|
May 4, 2016
A Case of Lagochilascariasis in Suriname with the Involvement of the ENT System and the Skull Base
Joeri A J Douma, Ralph A E Akrum, Rudie Tjong Tjin Joe, et al.
JCO Clinical Cancer Informatics
|
June 30, 2025
Machine Learning-Based Prediction of Clinical Outcomes in Patients With Cancer Receiving Systemic Treatment Using Step Count Data Measured With Smartphones
Calvin G Brouwer, Branca M Bartelet, Joeri A J Douma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 25, 2020
Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
Joeri A J Douma, Sonja Zweegman, Mieke Alberts, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 22, 2024
Decline in Smartphone-Assessed Physical Activity Level is Associated With Clinical Outcomes in Phase I/II Clinical Cancer Trials
Calvin G Brouwer, Joeri A J Douma, Evelien J M Kuip, et al.
Cancers
|
June 2, 2021
Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
Joeri A J Douma, Laurien M Buffart, Ramy Sedhom, et al.
Journal of Clinical Pharmacology
|
October 4, 2023
Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam
Lisa T van der Heijden, Claire A Ribbers, Marit A C Vermunt, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Nederlands Tijdschrift Voor Geneeskunde
|
July 10, 2014
[A dyspnoeic male with abnormal QRS complexes]
Joeri A J Douma, Jeroen Schotten
Nederlands Tijdschrift Voor Geneeskunde
|
August 7, 2015
[Loperamide for acute infectious diarrhoea]
Joeri A J Douma, Yvo M Smulders
Nederlands Tijdschrift Voor Geneeskunde
|
December 5, 2013
[A woman with acute abdominal pain in the night]
Joeri A J Douma, Frans van Hoorn, Rob J L Klaassen
BMC Cancer
|
October 31, 2018
Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer
Joeri A J Douma, Henk M W Verheul, Laurien M Buffart
The American Journal of Tropical Medicine and Hygiene
|
May 4, 2016
A Case of Lagochilascariasis in Suriname with the Involvement of the ENT System and the Skull Base
Joeri A J Douma, Ralph A E Akrum, Rudie Tjong Tjin Joe, et al.
JCO Clinical Cancer Informatics
|
June 30, 2025
Machine Learning-Based Prediction of Clinical Outcomes in Patients With Cancer Receiving Systemic Treatment Using Step Count Data Measured With Smartphones
Calvin G Brouwer, Branca M Bartelet, Joeri A J Douma, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 25, 2020
Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
Joeri A J Douma, Sonja Zweegman, Mieke Alberts, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 22, 2024
Decline in Smartphone-Assessed Physical Activity Level is Associated With Clinical Outcomes in Phase I/II Clinical Cancer Trials
Calvin G Brouwer, Joeri A J Douma, Evelien J M Kuip, et al.
Cancers
|
June 2, 2021
Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
Joeri A J Douma, Laurien M Buffart, Ramy Sedhom, et al.
Journal of Clinical Pharmacology
|
October 4, 2023
Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam
Lisa T van der Heijden, Claire A Ribbers, Marit A C Vermunt, et al.
Page
of 2